Abstract
Acute acquired comitant esotropia (AACE) is mainly characterized by sudden onset, accompanied by diplopia, without extraocular muscles paralysis or ocular motility disorders. In recent years, the incidence of AACE has been increasing, researchers have found that this phenomenon may be related to the widespread use of electronic devices and the increase in the number of people working from home during the COVID-19 pandemic. However, its neural mechanisms have not been fully elucidated. This article primarily reviews the latest developments in the diagnosis and treatment of AACE from the perspectives of etiology and treatment methods, aiming to provide direction for future in-depth exploration of the pathogenesis and treatment approaches of this disease.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Acute acquired comitant esotropia (AACE) is characterized by sudden onset of strabismus, accompanied by diplopia, with no significant changes in the deviation angle in different gaze positions. AACE accounting for 0.3% of strabismus cases in children [1] and it has been reported that older children and adults have been more susceptible to AACE. The incidence of AACE has risen recently, likely due to the increased use of electronic devices and the growth in home-based work prompted by the COVID-19 pandemic [2,3,4]. Among cases involving refractive errors, myopia is the most common, with 90% of adult AACE patients experiencing myopia [5]. Hyperopia is more common in pediatric AACE patients, which may be related to physiological hyperopia in children [6]. The study by Sturm et al. [7] investigated the clinical characteristics of 24 children with AACE, all of whom were aged three years or younger, with all 24 patients were classified as the Franceschetti type (mentioned in the next paragraph).
Methods
Literature was collected from Web of Science, Medline and Pubmed using the terms: ‘‘acute acquired comitant esotropia’’, “acute onset esotropia”, ‘‘diagnosis’’ and ‘‘treatment’’. By reviewing abstracts, we summarized the classification, etiology, diagnosis, and treatment of AACE, aiming to identify gaps in the field and provide insights for future research and clinical practice (Flowchart see Fig. 1).
Clinical classification and characteristics
In 1958, Burian et al. first divided AACE into three types [8]. This classification method is still widely used today and is the most wide-used classification in clinics. Type I (Swan type), firstly proposed by Swan in 1947 [9], often develops following monocular occlusion or a decline in monocular vision due to illness, resulting from the disruption of binocular fusion function. Type II (Burian-Franceschetti type) is common in patients with mild hyperopia [7], characterized by a larger degree of strabismus [7] and a smaller accommodative factor [7], this type often occur after severe illness or psychosomatic trauma. Type III (Bielschowsky type) involves patients with myopia (up to 5.00 D), where diplopia occurs at distance but disappears at near. Some scholars believed that there had been no significant distinction between Type II and Type III, with refractive errors primarily associated with patient age, and they propose a classification based on the degree of strabismus which appears to be more effective for clinical diagnosis and treatment [10]. Buch et al. [6], in their research on 48 children with AACE, classified pediatric AACE into seven types, including Occlusion-related AACE; Idiopathic AACE; Acute accommodative AACE; Decompensated AACE; Neurological AACE; Cyclic AACE; Secondary AACE. Notably, the traditional Bielschowsky type was not observed in this study. Additionally, owing to children's physiological hyperopia, hyperopia is comparatively frequent in pediatric AACE patients. However, the controversy of classification of AACE was attribute to unknown etiology.
Etiology
The specific pathogenesis of AACE remains unclear to this day. Based on a comprehensive analysis of existing reports, the causes of AACE can be categorized into the following types (see Table 1).
Excessive near visual activities
Prolonged engagement in close visual activities, such as using electronic devices, studying, assembling or repairing precision equipment, may be a significant risk factor for AACE [2, 8, 11,12,13,14,15]. Excessive near-work activities may lead to increased tension in the medial rectus muscle, thereby disrupting motor fusion; overuse of digital devices at night significantly affects visual motion processing and ocular adjustment, resulting in the breakdown of motor and sensory fusion, thereby triggering the disease [2]. Roda et al., in their study of 117 AACE patients, hypothesized that long-term near-work activities may weaken the ability to relax fusion from near to distance vision, explaining why 94% of the patients experience diplopia at distant viewing points [12]. Studies have found that reducing near-work time helps decrease the degree of strabismus in AACE patients [13, 16, 17]. For patients excessively engaged in near visual activities, methods such as correcting myopia and reducing the use of electronic devices can effectively decrease their daily time spent on near visual activities, thereby reducing the impact of this factor.
Abnormal convergence and accommodation
Convergence spasm may be a cause of Bielschowsky type and AACE associated with prolonged close-work [11, 13, 18, 19]. In over-corrected myopic patients, convergence spasm may arise from excessive accommodation and convergence while viewing close objects, and spasm do not relax during distant viewing, thus leading to diplopia. Research by Lee et al. indicates that excessive use of electronic devices at close range could result in increased visual accommodation requirements, thereby provoking excessive accommodation and triggering the disease [20]. A study involving 22 AACE patients revealed that their average accommodation convergence/accommodation (AC/A) ratio exceeded normal range, implying that excessive convergence might be a trait of AACE. The study further noted that the accommodation capacity of these patients is below that of age-matched healthy individuals. The deficiency in accommodation leads to increased convergence during close-work activities, resulting in chronic overuse of the medial rectus muscles, upsetting the balance with the lateral rectus muscles, and thus leading to AACE [21].
Abnormal fusional vergence
Patients with AACE exhibit abnormalities in fusional vergence movements. Swan type and AACE associated long-term occlusion therapy is associated with abnormalities in fusion function [8, 22]. Research by Roda et al. discovered a negative correlation between the deviation angle during diplopia episodes and age, hypothesizing a reduction in fusional reserves with aging. This could account for the occurrence of diplopia in the elderly with smaller esotropia angles [12]. A reduced fusional divergence amplitude may be one of the causes of AACE onset [18].The development of Type II AACE could be associated with a diminished fusional divergence amplitude [18]. In a study involving 8 AACE patients, Ali et al. discovered that their patients did not fit into any type of the traditional classification, indicating that their conditions resulted from decompensation of esophoria due to inadequate compensatory enhancement of fusional divergence amplitude [23]. A prospective study also found fusional vergence dysfunction in adult AACE, with reduced fusional convergence amplitude and increased fusional divergence amplitude, which may be an adaptive phenomenon for esotropia to maintain fusion in AACE patients [24]. Both reduced and increased fusional divergence amplitudes have been found in AACE, because their etiology is different. The increased fusional divergence amplitudes acts as a compensatory factor. The decreased fusional divergence amplitudes is due to excessive near vision activities or reduced fusional reserves. In AACE, fusional convergence is related to the degree of myopia, the more severe the myopia, the greater the fusional convergence in AACE.
Extraocular muscle tension alteration
Changes in the tension and position of the medial rectus muscle may be a factor leading to AACE. Researchers have proposed that excessive close-range visual activities might heighten the muscular tension in the medial rectus muscles, simultaneously reduce the tension in the lateral rectus muscles [8, 25, 26] and cause lateral rectus atrophy [27]. Magnetic resonance imaging(MRI) can be used to observe the morphological and positional changes of the extraocular muscles in strabismus patients, providing a reference for subsequent MRI studies on the changes in the extraocular muscles in AACE [28]. Research has discovered that in patients with AACE, there are significant changes in the muscle size and volume in the dominant eye, which are adaptations to their visual problems and solutions to the issue of double vision [29]. A Study indicates that the insertion site of the medial rectus muscle remains the most consistent across all extraocular muscles, irrespective of the patient's ethnic background [30]. Some research has found that in AACE patients, the distance from the conjunctival insertion point of the medial rectus muscle to the limbus is relatively short, which may enhance convergence ability, disrupt the balance between convergence and divergence, and subsequently lead to AACE [31, 32].
Central nervous system dysfunction
Previous studies have found abnormalities in brain functional areas in patients with non-AACE strabismus. Studies on animal models of strabismus have shown a decrease in the number of binocular neurons in the V1 and V2 areas of the visual cortex, and these neurons can’t regenerate once lost, even if binocular vision returns [33]. Binocular neurons are fundamental to the development of stereopsis [34], which helps explain why strabismus patients often exhibit binocular visual impairments. Research on strabismic cat models found that strabismus affects the internal and inter-regional neural connections within the cat's visual cortex. Strabismus leads to the segregation of ocular dominance domain in the primary visual cortex (area 17) and alters the connections within area 18 and between areas 17 and 18 [35]. Studies on strabismic monkey models have found that the disruption of binocular fusion may lead to connection defects in the V1 area and potentially induce esotropia [36]. Scholars have used resting-state functional magnetic resonance imaging (rs-fMRI) to investigate cortical abnormalities in AACE patients [37]. This study collected and analyzed rs-fMRI signal data from 25 AACE patients and a matched control group of 25. Compared to the control group, the primary visual cortex and dorsal pathway in AACE patients exhibited significant changes in the amplitude of low-frequency fluctuations (ALFF), and these changes were correlated with clinical characteristics such as age of onset, time spent on near work activities, and deviation angle of strabismus. These findings not only reveal the connection between AACE and the visual center but also provide new clues for understanding the pathogenesis and therapeutic approaches of AACE.
Neurological diseases
The appearance of AACE may associate with neurological disease, include Chiari I malformation [38,39,40], cerebellar astrocytoma [41,42,43], cerebellar medulloblastoma [44], diffuse intrinsic pontine glioma [45]. Some scholars believe that intracranial diseases causing AACE are due to lesions affecting the vergence mechanism of midbrain [46, 47]. Others suggest that combined damage to the thalamus and midbrain can affect convergence function, leading to the occurrence of AACE [48]. One study found that patients developed AACE after receiving high doses of carbamazepine, which resolved after dose reduction. However, this is the only resarch suggesting a connection between AACE and medication, indicating a need for further research to explore this association [49]. A study by Yatziv et al. found that epidural puncture decreases intracranial pressure, causing stretching injury to the abducens nerve, leading to comitant esotropia [50].
There is still controversy regarding whether AACE patients require neurological examinations. Some scholars suggest a comprehensive neurological assessment for AACE patients [19], especially in cases with nystagmus or other abnormal ocular and neurological signs (such as cerebellar ataxia, papilledema and so on) [10, 51,52,53,54]. Some scholars believe that the possibility of intracranial disease should still be considered even if the patient does not exhibit other neurological and ocular symptoms [55]. Buch et al. [6], based on their study of 48 children, found that 6% cases involved intracranial diseases. They proposed four risk factors for pediatric AACE: neurological symptoms, large deviation angle at distance, recurrent AACE, and older age at onset. These risk factors can guide clinicians in deciding when to perform brain imaging. Patients without neurological and ocular abnormal manifestations have a low likelihood of underlying intracranial disease [56, 57]. When treating AACE, the most important consideration is that AACE may be the initial symptom of a neurological disorder. Since most of the neurological conditions are serious, patient must undergo immediate imaing, followed by close monitoring and assessment for signs of intracranial disease [58,59,60].
The angle of deviation at near and distance fixation also varies among AACE patients. For most patients, the angle of deviation is greater at distance than at near, which may be related to divergence insufficiency [61], excessive near vision activity [62], higher divergent fusional amplitudes at near [15], and intracranial pathological causes. As the disease progresses, the angles of deviation at near and distance tend to become similar. There are also patients whose angle of deviation at near is greater than at distance, which may be associated with convergence excess-induced AACE.
Treatment and prognosis
There are currently no explicit guidelines for the clinical treatment of AACE, and its treatment methods are still a subject of debate. AACE does not resolve spontaneously, and the vast majority of patients require treatment. Treatment methods for AACE include refractive errors correction, medication [63, 64], occlusion therapy, pharmacological therapy [65], prism therapy, botulinum toxin injections, and surgery. It has been reported that eliminating environmental factors can lessen the severity of esotropia [13, 16, 17]. Environmental factors, like the excessive use of mobile phones and digital screens at close range, must be considered before formulating a treatment strategy. Vision correction also need to take into consider, it is a prerequisite before implementing other treatments [54].
Differential diagnosis
AACE should be separate from the non-refractive accommodative esotropia(also named convergence excess esotropia) [66,67,68], divergence insufficiency [69,70,71,72,73] and decompensated esophoria [74, 75].
We summarize the characteristics (such as deviation angle, diplopia, prism adaptation test, AC/A ratio, fusional amplitudes) of AACE [15, 21, 24, 76] and the terms mentioned above (see Table 2).
It is worth noting that there is an overlap between AACE and convergence excess esotropia, divergence insufficiency, and decompensated esotropia. Based on the above analysis of etiology, it can be observed that some AACE patients may exhibit characteristics such as excessive convergence, reduction in fusional reserves, and reduced fusional divergence amplitude.
AACE also need to seperate from sagging eye syndrome, wich can also present with distance esotropia. We can differentiate based on characteristics such as cyclovertical strabismus, limited supraduction, and blepharoptosis [77].
Prism therapy
For patients with esotropia less than 15PD, prism therapy can be considered [54]. For strabismus cases not exceeding 25 PD, progressive prism therapy has demonstrated positive results in accommodative movement and binocular vision [78].
Botulinum toxin injection therapy
Botulinum toxin therapy involves injecting botulinum toxin into the medial rectus muscle to weaken its strength and thus improve the condition of strabismus. There are several methods for injecting BTXA, including microinjection through a small conjunctival incision [79, 80], electromyography(EMG) guided injection without a conjunctival incision [81], and direct conjunctival injection without an incision or EMG [79, 82,83,84,85,86,87]. With advantages like minimal invasiveness, simplicity, low cost, and rapid recovery, BTXA treatment is still a feasible choice for patients with minor strabismus angles and those who urgently require treatment with an unstable strabismus degree for less than six months.
The metabolic characteristics of botulinum toxin indicate that the efficacy of the treatment can be ascertained only after several months. Studies show that the residual angle of deviation and success rate six months after botulinum toxin treatment are related to the angle of deviation two weeks into the treatment. Thus, the deviation angle at two weeks can serve as an indicator of early treatment effectiveness, predicting long-term efficacy [82]. Botulinum toxin treatment is dose-dependent, so selecting the appropriate injection dose based on the angle of strabismus can enhance the success rate of the treatment. Xu et al. [33] selected injection doses according to the degree of strabismus, achieving a six-month follow-up success rate of 86.2% and a final follow-up success rate of 82.2% [79].
We have compiled a table summarizing research on the use of botulinum toxin in AACE, with studies meeting the following criteria: published within the last decade, at least six months follow-up, and a single botulinum toxin injection. The aim is to investigate the effectiveness and feasibility of botulinum toxin in the management of AACE from a quantitative perspective (see Table 3) [79, 80, 82,83,84,85,86,87].
There is still no definitive conclusion regarding the comparative effectiveness of botulinum toxin treatment versus surgery, with some studies indicating similar therapeutic outcomes for both approaches [83,84,85, 88, 89]. Yu et al. compared the effects of BTXA injections with high-dose surgical treatment, and their two-year follow-up found that the recurrence rate in the BTXA group was significantly higher than that in the surgical group [87]. Suwannaraj et al. [86] also concluded that surgical treatment is more effective than botulinum toxin injections, but this conclusion is limited as all patients received the same dose of BTXA, without considering the dose-dependent effects of botulinum toxin, thus limiting the reference value of their conclusion.
Surgical treatment
Surgical therapy primarily aims to correct strabismus and eradicate diplopia. Surgical intervention is essential for patients with significant strabismus. Common surgical procedures include bilateral/unilateral medial rectus recession (MRrec) [11] and unilateral MRrec + unilateral rectus resection (LRres) [5, 90, 91]. Currently, there is no clear evidence indicating the difference in efficacy between these two surgical methods, so surgeons usually select the surgical approach based on their clinical experience. Some scholars believe that for patients with a large angle of strabismus, unilateral MRrec + unilateral LRres is more effective than bilateral/unilateral MRrec, and shortening the lateral rectus muscle can effectively reduce the risk of postoperative recurrence and leave a fresh eye, which may be beneficial for possible future surgical needs [92]. Methods to evaluate surgical outcomes include assessing residual strabismus and its severity, recurrence of diplopia [12], restoration of stereopsis [93], and the balance in visual dominance [94]. The effectiveness of surgical treatment is influenced by various factors, which will be explained in the following sections.
Patient baseline conditions: Better vision acuity can help improve postoperative sensory fusion; The success rate of surgery in elderly patients may be reduced due to factors such as degeneration of periocular tissues [12].
Angle of deviation: Surgical is most appropriate when the deviation angle stabilizes following at least six months conservative treatment [54].
Selection of Surgical Dosage: In AACE surgical treatment, choosing the appropriate surgical dosage is a key focus, but there are currently no definitive guidelines for selecting surgical dosages in AACE. Many scholars suggest increasing the dosage of bilateral medial rectus recession (BMR) surgeries [12, 23, 95, 96]. In eight cases of BMR surgery performed by Ali et al. based on Park's surgical table, five cases (71%) had residual strabismus of 2PD-14PD postoperatively [23]. Lee et al. [96] performed augmented-dosage BMR surgeries on 16 patients, achieving a postoperative success rate of 75%. Regarding unilateral MRrec + unilateral LRres(RR) surgery, Zhou et al. [92] proposed that the RR surgical dosage for AACE patients should be greater than that for typical esotropia patients, and they were the first to propose the dose–response reference of RR in AACE. For patients with a deviation of less than 30 diopters, the dose–response ratios for MRrec and LRres are 5.11 PD/mm and 2.51 PD/mm, respectively. In cases where the deviation is greater than or equal to 30 diopters, an additional LRres has a dose–response ratio of 5.48 PD/mm to address the excess deviation over 30 diopters. Further research has introduced the dose–response reference for MRrec surgery, like Zhou's approach, using 30PD as the cut-off point [87]. The prism adaptation test(PAT) can reveal the potential angle of strabismus, and using this angle as the surgical target can help improve binocular function and reduce the recurrence rate of AACE [15, 54, 97]. However, PAT requires patient highly compliance, limiting its clinical application value. A study used the preoperative Base-out (BO) recovery point as the target surgical amount, and the results showed that 86.4% patients maintained normal eye position during an average follow-up period of 15.8 months [98]. Compared to PAT, this measurement method is simpler and more convenient, demonstrating higher clinical application value. Research also indicates that using the maximum angle of strabismus measured after one hour of occlusion as the surgical target (with 14 patients showing an increase in esodeviation of more than 5 prism diopters after occlusion), combined with the non-adjustable suture technique, resulted in favorable outcomes [99]. Another study [100] compared the treatment effects using Maddox rod prism degrees and prism and alternate cover test(PACT) degrees as target amounts for AACE surgery. Data analysis revealed that, The Maddox rod prism method is capable of detecting a higher degree of strabismus in patients with AACE. Utilizing this measurement as a target metric significantly reduces residual strabismus and increases the success rate of surgical interventions. Consequently, it is advisable to incorporate the Maddox rod prism as a standard preoperative assessment technique for patients with AACE.
Postoperative Lifestyle: The use of electronic devices should be appropriately limited after surgery. This is particularly important for younger patients who are unable to manage their time spent on electronic devices responsibly, leading to a higher probability of recurrence and double vision post-surgery compared to adults. For these patients, strict management of electronic device usage time is necessary [101].
Patients with AACE have the potential to recover normal stereopsis [10, 93]. The time from the onset of the condition to the start of treatment does not seem to be a critical factor in the recovery of normal stereopsis [61, 93, 102]. Another study has discovered that improvements in the angles of esotropia are negatively correlated with the length of untreated time, highlighting the significance of early intervention to avert further deterioration of esotropia [65]. Sturm et al., based on a study of 22 Type II AACE patients, found that the interval between the onset of esotropia and surgery was similar among patients with normal stereopsis and those with absent or lower levels of stereopsis (23 months compared to 24 months), the study also found that the recovery interval for stereopsis was surprisingly long, with the authors suggesting a correlation with patients who had undiagnosed monocular fixation syndrome [93]. Subsequent research revealed that Bagolini striated lenses and the Worth four-dot test could differentiate between AACE and monocular fixation syndrome [103]. In observing the postoperative outcomes of AACE, Kim et al. [90] considered patients with unrecovered stereopsis to have uncompensated monocular fixation syndrome.
Conclusions and future perspectives
AACE has seen an increase in research in recent years due to the rising incidence of this condition. Currently, research on AACE still faces several knowledge gaps: the classification, causes of the disease, choices of treatment methods, and factors affecting treatment efficacy. People with AACE have many problems such as convergence, accommodation, and fusional amplitudes. These patients should receive a comprehensive examination including measurements of deviation angles at near and distance fixation, fusional amplitudes, AC/A ratio, near point accommodation (NPA), near point convergence (NPC), and accommodative facility.
Future research needs to delve deeper into the etiology of AACE, especialy with advanced neuroimaging techniques such as Electroencephalograph (EEG), fMRI. More RCT studies need to perform in preferred treatment in small-angle AACE to form guideline of AACE treatment.
Abbreviations
- AACE:
-
Acute acquired comitant esotropia
- AC/A:
-
Accommodation convergence/accommodation
- MRI:
-
Magnetic resonance imaging
- rs-fMRI:
-
Resting-state functional magnetic resonance imaging
- ALFF:
-
Amplitude of low-frequency fluctuations
- EMG:
-
Electromyography
- MRrec:
-
Medial rectus recession
- LRres:
-
Lateral rectus resection
- BMR:
-
Bilateral medial rectus recession
- RR:
-
Unilateral medial rectus recession + unilateral Lateral rectus resection
- PAT:
-
Prism adaptation test
- BO:
-
Base-out
- PACT:
-
Prism and alternate cover test
- EEG:
-
Electroencephalograph
- NPA:
-
Near point accommodation
- NPC:
-
Near point convergence
References
Mohney BG (2007) Common forms of childhood strabismus in an incidence cohort. Am J Ophthalmol 144(3):465–467
Zhu M, Tang Y, Wang Z, Shen T, Qiu X, Yan J et al (2023) Clinical characteristics and risk factors of acute acquired concomitant esotropia in last 5 years: a retrospective case-control study. Eye (Lond) 37(2):320–324
Pujara P, Carter D, Bolton K, Nicholson R (2023) 20 Simultaneous development of acute acquired concomitant esotropia in two siblings during the COVID-19 pandemic: a case report. BMJ open ophthalmology 8(Suppl 3):A7
Okita Y, Kimura A, Masuda A, Mochizuki Y, Kondo M, Yamadera K et al (2023) Yearly changes in cases of acute acquired comitant esotropia during a 12-year period. Graefe’s Arch Clin Exp Ophthalmol 261(9):2661–2668
Spierer A (2003) Acute concomitant esotropia of adulthood. Ophthalmology 110(5):1053–1056
Buch H, Vinding T (2015) Acute acquired comitant esotropia of childhood: a classification based on 48 children. Acta Ophthalmol 93(6):568–574
Sturm V, Menke MN, Töteberg M, Jaggi GP, Schoeffler C (2012) Early onset of acquired comitant non-accommodative esotropia in childhood. Klin Monatsbl Augenheilkd 229(4):357–361
Burian HM, Miller JE (1958) Comitant convergent strabismus with acute onset. Am J Ophthalmol 45:55–64
Swan KC (1947) Esotropia following occlusion. Arch Ophthalmol 37(4):444–451
Chen J, Deng D, Sun Y, Shen T, Cao G, Yan J et al (2015) Acute acquired concomitant esotropia: clinical features, classification, and etiology. Medicine 94(51):e2273
Yagasaki T, Yokoyama Y, Yagasaki A, Eboshita R, Tagami K, Haga Y et al (2023) Surgical outcomes with and without prism adaptation of cases with acute acquired comitant esotropia related to prolonged digital device use. Clin Ophthalmol 17:807–816
Roda M, di Geronimo N, Valsecchi N, Gardini L, Fresina M, Vagge A et al (2023) Epidemiology, clinical features, and surgical outcomes of acute acquired concomitant esotropia associated with myopia. PLoS ONE 18(5):e0280968
Nouraeinejad A (2023) Letter to the editor: environmentally driven abnormalities in accommodation and vergence can be one of the causes of acute acquired comitant esotropia. Optom Vis Sci Off Publ Am Acad of Optom 100(3):238
Lekskul A, Chotkajornkiat N, Wuthisiri W, Tangtammaruk P (2021) Acute acquired comitant esotropia: etiology, clinical course, and management. Clin Ophthalmol 15:1567–1572
Ruatta C, Schiavi C (2020) Acute acquired concomitant esotropia associated with myopia: is the condition related to any binocular function failure? Graefe’s Arch Clin Exp Ophthalmol 258(11):2509–2515
Neena R, Remya S, Anantharaman G (2022) Acute acquired comitant esotropia precipitated by excessive near work during the COVID-19-induced home confinement. Indian J Ophthalmol 70(4):1359–1364
Vagge A, Giannaccare G, Scarinci F, Cacciamani A, Pellegrini M, Bernabei F et al (2020) Acute acquired concomitant esotropia from excessive application of near vision during the COVID-19 lockdown. J Pediatr Ophthalmol Strabismus 57:e88–e91
Campos EC (2008) Why do the eyes cross? A review and discussion of the nature and origin of essential infantile esotropia, microstrabismus, accommodative esotropia, and acute comitant esotropia. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus 12(4):326–331
Kemmanu V, Hegde K, Seetharam R, Shetty BK (2012) Varied aetiology of acute acquired comitant esotropia: a case series. Oman J Ophthalmol 5(2):103–105
Lee HS, Park SW, Heo H (2016) Acute acquired comitant esotropia related to excessive smartphone use. BMC Ophthalmol 16:37
Tong L, Yu X, Tang X, Zhang Y, Zheng S, Sun Z (2020) Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection. BMC Ophthalmol 20(1):464
Rutstein RP, Lee SD, Zimmerman DR (2017) Atypical presentation of acute acquired comitant esotropia. Clin Exp Optom 100(2):192–194
Ali MH, Berry S, Qureshi A, Rattanalert N, Demer JL (2018) Decompensated esophoria as a benign cause of acquired esotropia. Am J Ophthalmol 194:95–100
Zhao S, Hao J, Liu J, Cao K, Fu J (2022) Fusional vergence dysfunctions in acute acquired concomitant esotropia of adulthood with myopia. Ophthalmic Res 66:320
Erkan Turan K, Kansu T (2016) Acute acquired comitant esotropia in adults: is it neurologic or not? J Ophthalmol 2016:2856128
Webb H, Lee J (2004) Acquired distance esotropia associated with myopia. Strabismus 12(3):149–155
Gupta N, Pradhan KR, Chopra G, Khadka S (2022) A rare presentation of esotropia in high myopia in a young adult: a case report. Oxford Med case Rep 12:137
Hao R, Zhang W, Zhao K (2018) Magnetic resonance imaging study of extraocular rectus muscles in intermittent exotropia. Chin J Optom Ophthalmol Vis Sci 20(5):261–264
Chen JY, Zhang LR, Liu JW, Hao J, Li HX, Zhang QY et al (2024) Magnetic resonance imaging of extraocular rectus muscles abnormalities in acute acquired concomitant esotropia. Int J Ophthalmol 17(1):119–125
Lai YH, Wu WC, Wang HZ, Hsu HT (2012) Extraocular muscle insertion positions and outcomes of strabismus surgery: correlation analysis and anatomical comparison of Western and Chinese populations. Br J Ophthalmol 96(5):679–682
Cai C, Dai H, Shen Y (2019) Clinical characteristics and surgical outcomes of acute acquired comitant esotropia. BMC Ophthalmol 19(1):173
Hayashi R, Hayashi S, Nishimura T, Machida S (2024) Conformation of horizontal extraocular muscle insertions in acute acquired concomitant esotropia induced by excessive digital device usage. Clin Ophthalmol 18:41–47
Crawford ML, Smith EL 3rd, Harwerth RS, von Noorden GK (1984) Stereoblind monkeys have few binocular neurons. Invest Ophthalmol Vis Sci 25(7):779–781
Qian N (1997) Binocular disparity and the perception of depth. Neuron 18(3):359–368
Schmidt KF, Löwel S (2008) Strabismus modifies intrinsic and inter-areal connections in cat area 18. Neuroscience 152(1):128–137
Tychsen L (2007) Causing and curing infantile esotropia in primates: the role of decorrelated binocular input (an American ophthalmological society thesis). Trans Am Ophthalmol Soc 105:564–593
Hu Y, Wang S, Wu L, Xi S, Wen W, Zhao C (2023) Deficits of visual cortex function in acute acquired concomitant esotropia patients. Invest Ophthalmol Vis Sci 64(13):46
Biousse V, Newman NJ, Petermann SH, Lambert SR (2000) Isolated comitant esotropia and Chiari I malformation. Am J Ophthalmol 130(2):216–220
Hentschel SJ, Yen KG, Lang FF (2005) Chiari I malformation and acute acquired comitant esotropia: case report and review of the literature. J Neurosurg 102(4 Suppl):407–412
Weeks CL, Hamed LM (1999) Treatment of acute comitant esotropia in Chiari I malformation. Ophthalmology 106(12):2368–2371
Lee JM, Kim SH, Lee JI, Ryou JY, Kim SY (2009) Acute comitant esotropia in a child with a cerebellar tumor. Korean J Ophthalmol KJO 23(3):228–231
Dikici K, Cicik E, Akman C, Kendiroğlu G, Tolun H (1999) Cerebellar astrocytoma presenting with acute esotropia in a 5 year-old girl. Case Rep Int Ophthalmol 23(3):167–170
Musazadeh M, Hartmann K, Simon F (2004) Late onset esotropia as first symptom of a cerebellar tumor. Strabismus 12(2):119–123
Zweifach PH (1981) Childhood esotropia with delayed appearance of cerebellar tumor. Neuro-Ophthalmology 1(4):291–293
Osborne D, Richardson-May J, Bush K, Evans M, West SK, May K et al (2023) Four cases of acute comitant esotropia associated with diffuse intrinsic pontine glioma in children. Strabismus 31(1):26–30
Bixenman W, Laguna JF, Laguna JF (1987) Acquired esotropia as initial manifestation of Arnold-Chiari malformation. J Pediatric Ophthalmol Strabismus 24:83–86
Lennerstrand G, Gallo JE, Samuelsson L (1990) Neuro-ophthalmological findings in relation to CNS lesions in patients with myelomeningocele. Develop Med Child Neurol 32:423–431
Wong AMF (2008) Eye movement disorders. Oxford University Press, Oxford
Fukuo Y, Abe T, Hayasaka S (1998) Acute comitant esotropia in a boy with head trauma and convulsions receiving carbamazepine. Ophthalmol J Int D’ophtalmologie Int J Ophthalmol Zeitschrift fur Augenheilkunde 212(1):61–62
Yatziv Y, Stolowitch C, Segev Y, Kesler A (2008) Acute esotropia after epidural anesthesia. Obstet Gynecol 111(2 Pt 2):540–541
Nouraeinejad A (2023) Neurological pathologies in acute acquired comitant esotropia. Graefe’s for Clin Exp Ophthalmol 261:1–8
Hoyt CS, Good WV (1995) Acute onset concomitant esotropia: when is it a sign of serious neurological disease? Br J Ophthalmol 79(5):498–501
Nouraeinejad A (2023) Neurological pathologies associated with acute acquired comitant esotropia. Int J Neurosci 261:1–2
Nouraeinejad A (2023) To prioritize treatment options for acute acquired comitant esotropia. Eur J Ophthalmol 33(4):145–146
Gilbert ME, Meira D, Foroozan R, Edmond J, Phillips P (2006) Double vision worth a double take. Surv Ophthalmol 51(6):587–591
Legmann Simon A, Borchert M (1997) Etiology and prognosis of acute, late-onset esotropia. Ophthalmology 104(8):1348–1352
Lyons CJ, Tiffin PA, Oystreck D (1999) Acute acquired comitant esotropia: a prospective study. Eye (Lond) 13(Pt 5):617–620
Montriwet M (2023) Possibility of neurological diseases associated with acute acquired comitant esotropia. Korean J Ophthalmol KJO 37(2):120–127
Côté E, Reginald YA, Wan MJ (2024) Risk of serious intracranial pathology in children presenting with acute acquired comitant esotropia: a 20-year retrospective review. Can J Ophthalmol J Can d’ophtalmol. https://doi.org/10.1016/j.jcjo.2024.01.002
Yagasaki A, Miyase T, Sakai S, Mochizuki K, Sakaguchi H, Yagasaki T et al (2023) Two pediatric patients with acute acquired comitant esotropia as the first symptom of brainstem tumor: a case report. Case Rep Ophthalmol 14(1):613–619
Fu T, Wang J, Levin M, Xi P, Li D, Li J (2017) Clinical features of acute acquired comitant esotropia in the Chinese populations. Medicine 96(46):e8528
Meng Y, Hu X, Huang X, Zhao Y, Ye M, Yi B et al (2022) Clinical characteristics and aetiology of acute acquired comitant esotropia. Clin Exp Optom 105(3):293–297
Hussaindeen JR, Mani R, Agarkar S, Ramani KK, Surendran TS (2014) Acute adult onset comitant esotropia associated with accommodative spasm. Optom Vis Sci Off Publ Am Acad Optom 91(4 Suppl 1):S46-51
Shanker V, Nigam V (2015) Unusual presentation of spasm of near reflex mimicking large-angle acute acquired comitant esotropia. Neuro-ophthalmology (Aeolus Press) 39(4):187–190
Hayashi R, Hayashi S, Machida S (2022) The effects of topical cycloplegics in acute acquired comitant esotropia induced by excessive digital device usage. BMC Ophthalmol 22(1):366
Kim WK, Kang SY, Rhiu S, Chung SA, Lee JB (2012) The analysis of AC/A ratio in nonrefractive accommodative esotropia treated with bifocal glasses. Korean J Ophthalmol 26:39
Fresina M, Schiavi C, Campos EC (2010) Do bifocals reduce accommodative amplitude in convergence excess esotropia? Graefe’s Arch Clin Exp Ophthalmol 248:1501–1505
Garretty T (2018) The effect of prism adaptation on the angle of deviation in convergence excess esotropia and possible consequences for surgical planning. Strabismus 26(3):111–117
Bruce GM (1935) Ocular divergence: its physiology and pathology. Arch Ophthalmol 13:639–660
Burian HM, Brown AW (1972) Unusual adverse effect of prismatic corrections in a child with divergence insufficiency. Am J Ophthalmol 74(2):336–339
Herlihy EP, Phillips JO, Weiss AH (2013) Esotropia greater at distance: children vs adults. JAMA Ophthalmol 131:370–375
Godts D, Mathysen DG (2013) Distance esotropia in the elderly. British J Ophthalmol 97(11):1415–1419
Wang JL, Dong LY, Cen J, Kang XL (2021) The surgical effects of medial rectus recession on divergence insufficiency esotropia. J Sichuan Univ 52:1011–1015
Gietzelt C, Fricke J, Neugebauer A, Hedergott AA (2022) Prism adaptation test before strabismus surgery in patients with decompensated esophoria and decompensated microesotropia. Int Ophthalmol 42:2195–2204
Arblaster GE, Shipman TL, Pepper IM (2009) Ompensating esophoria as the presenting feature of myasthenia gravis. J Am for Pediatric Ophthalmol Strabismus 13(3):310–311
Ela-Dalman N, Velez G, Thacker N, Britt MT, Velez FG (2006) Maximum motor fusion combined with one-hour preoperative prism adaptation test in patients with acquired esotropia. J Am Assoc Pediatr Ophthalmol Strabismus 10:561–564
Chaudhuri Z, Demer JL (2013) Sagging eye syndrome: connective tissue involution as a cause of horizontal and vertical strabismus in older patients. JAMA Ophthalmol 131(5):619–625
Wu Y, Feng X, Li J, Chang M, Wang J, Yan H (2022) Prismatic treatment of acute acquired concomitant esotropia of 25 prism diopters or less. BMC Ophthalmol 22(1):276
Xu H, Sun W, Dai S, Cheng Y, Zhao J, Liu Y et al (2020) Botulinum toxin injection with conjunctival microincision for the treatment of acute acquired comitant esotropia and its effectiveness. J Ophthalmol 2020:1702695
Huang XQ, Hu XM, Zhao YJ, Ye MH, Yi BX, Zhou LH (2022) Clinical efficacy of botulinum toxin type A on acute acquired comitant esotropia. Int J Ophthalmol 15(11):1845–1851
Dawson EL, Marshman WE, Adams GG (1999) The role of botulinum toxin A in acute-onset esotropia. Ophthalmology 106(9):1727–1730
Li Y, Tong L, Chen Y, Zhang B, Wan M, Yin X et al (2023) The efficacy of botulinum toxin type A treatment and surgery for acute acquired comitant esotropia. Front Med 10:1219419
Wan MJ, Mantagos IS, Shah AS, Kazlas M, Hunter DG (2017) Comparison of botulinum toxin with surgery for the treatment of acute-onset comitant esotropia in children. Am J Ophthalmol 176:33–39
Shi M, Zhou Y, Qin A, Cheng J, Ren H (2021) Treatment of acute acquired concomitant esotropia. BMC Ophthalmol 21(1):9
Lang LJ, Zhu Y, Li ZG, Zheng GY, Peng HY, Rong JB et al (2019) Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics. Sci Rep 9(1):13869
Suwannaraj S, Rojanasaksothron C, Methapisittikul Y, Wongwai P, Yospaiboon Y (2023) Botulinum toxin injection versus extraocular muscle surgery for acute acquired comitant esotropia. Clin Ophthalmol 17:413–420
Yu X, Pan W, Tang X, Zhang Y, Lou L, Zheng S et al (2023) Efficacy of augmented-dosed surgery versus botulinum toxin A injection for acute acquired concomitant esotropia: a 2-year follow-up. Br J Ophthalmol. https://doi.org/10.1136/bjo-2023-323646
Song D, Qian J, Chen Z (2023) Efficacy of botulinum toxin injection versus bilateral medial rectus recession for comitant esotropia: a meta-analysis. Graefe’s Arch Clin Exp Ophthalmol 261(5):1247–1256
Huang X, Meng Y, Hu X, Zhao Y, Ye M, Yi B et al (2022) the effect of different treatment methods on acute acquired concomitant esotropia. Comput Math Methods Med 2022:5001594
Kim DH, Noh HJ (2021) Surgical outcomes of acute acquired comitant esotropia of adulthood. BMC Ophthalmol 21(1):45
Kang W, Kim WJ (2021) Surgical outcomes of medial rectus recession and lateral rectus resection for large-angle deviations of acute acquired concomitant esotropia. Korean J Ophthalmol KJO 35(2):101–106
Zhou Y, Ling L, Wang X, Jiang C, Wen W, Zhao C (2023) Augmented-dose unilateral recession-resection procedure in acute acquired comitant esotropia. Ophthalmology 130(5):525–532
Sturm V, Menke MN, Knecht PB, Schöffler C (2011) Long-term follow-up of children with acute acquired concomitant esotropia. J AAPOS Off Publ Am for Pediatr Ophthalmol Strabismus 15(4):317–320
Shi C, Chen B, Yu X, Yao Z (2023) Sensory eye dominance following surgically correction for acute acquired concomitant esotropia of adulthood. Eur J Ophthalmol 33(1):83–91
Roda M, Pellegrini M, Rosti A, Fresina M, Schiavi C (2021) Augmented bimedial rectus muscles recession in acute acquired concomitant esotropia associated with myopia. Can J Ophthalmol J Can d’ophtalmol 56(3):166–170
Lee HJ, Kim SJ (2019) Clinical characteristics and surgical outcomes of adults with acute acquired comitant esotropia. Jpn J Ophthalmol 63(6):483–489
Zhang P, Zhang Y, Gao L, Yang J (2020) Comparison of the therapeutic effects of surgery following prism adaptation test versus surgery alone in acute acquired comitant esotropia. BMC Ophthalmol 20(1):303
Dai Z, Zheng F, Xu M, Zhou J, Wan M, Yu H et al (2021) Effect of the base-out recovery point as the surgical target for acute acquired comitant esotropia. Graefe’s Arch Clin Exp Ophthalmol 259(12):3787–3794
Lim SH, Lee YG, Kim US (2022) Non-adjustable surgery for acute acquired comitant esotropia under general anesthesia. BMC Ophthalmol 22(1):416
Tang K, Bi H, Song J, Liu J, Sha F, Liu Y et al (2023) Comparison of the surgical effects based on maddox prism test and prism and alternative cover test for acute acquired comitant esotropia. Chin J Optom Ophthalmol Vis Sci 25(4):285–290
Lim CW, Lee J, Kim WJ (2023) Changes in the number and characteristics of patients with acute acquired concomitant esotropia over time: an 8-year retrospective study. Medicine 102(22):e33986
Ohtsuki H, Hasebe S, Kobashi R, Okano M, Furuse T (1994) Critical period for restoration of normal stereoacuity in acute-onset comitant esotropia. Am J Ophthalmol 118(4):502–508
Savino G, Abed E, Rebecchi MT, Spreca M, Tredici C, Dickmann A (2016) Acute acquired concomitant esotropia and decompensated monofixation syndrome: a sensory-motor status assessment. Can J Ophthalmol J Can d’ophtalmol 51(4):258–264
Funding
This study was supported by National Natural Science Foundation of China (82271117 and 81500752 [W.W.], 82020108006 and 81730025 [C.Z.]); Shanghai Science and Technology Innovation Action Plan (grant 22ZR1410200 [W.W.]).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by ZYL, XSD. The first draft of the manuscript was written by GSY. The manuscript was critically reviewed by WW, ZC. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Consent for publication
This study does not contain any individual person’s data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Guo, S., Zhou, Y., Xi, S. et al. Advances in the diagnosis and treatment of acute acquired comitant esotropia. Int Ophthalmol 44, 315 (2024). https://doi.org/10.1007/s10792-024-03231-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10792-024-03231-5